Neumora Therapeutics Bolsa (NASDAQ: NMRA)

Últimas noticias sobre Neumora Therapeutics (NASDAQ:NMRA) Bolsa

NEUMORA THERAPEUTICS INC

Neumora Therapeutics

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics Inc

Macro Economic Events

News

Economics

China's Additional Tariffs On U.S. Goods To Take Effect From April 10

B of A Securities analyst Justin Post maintains Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) with a Buy and lowers the price target from $765 to $640.

Price Target

Analyst Ratings

B of A Securities Maintains Buy on Meta Platforms, Lowers Price Target to $640

NEHC

New Era Helium Provides Operational Update on Facility Development: Eyes Q4 2025 Plant Start, Accelerates AI Data Center Expansion Amid Financing Delays Aand Ongoing Midstream Negotiations

China Finance Ministry: To Impose Additional Tariffs Of 84% On U.S. Goods

Keybanc analyst Paul Knight downgrades Bio-Techne (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TECH#NASDAQ">TECH</a>) from Overweight to Sector Weight.

Downgrades

TECH

Keybanc Downgrades Bio-Techne to Sector Weight

GRMN

Garmin Announced The Varia Vue Headlight Camera, The Latest Addition To Its Lineup Of Accessories Designed To Help Increase Safety And Visibility For Cyclists Riding On Roadways

Simply Good Foods (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMPL#NASDAQ">SMPL</a>) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.40 by 15 percent. This is a 15 percent increase over earnings of $0.40 per share from the same period last year. The company reported quarterly sales of $359.65 million which beat the analyst consensus estimate of $354.40 million by 1.48 percent. This is a 15.20 percent increase over sales of $312.20 million the same period last year.

Earnings

Earnings Beats

SMPL

Simply Good Foods Q2 Adj $0.46 Beats $0.40 Estimate, Sales $359.65M Beat $354.40M Estimate

A blockchain analytics firm revealed that over&nbsp;$30 million worth of Official Melania&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">MELANIA</a>) meme coins were quietly sold, raising questions about the transparency of the project team and Hayden Davis.
What Happened: According to blockchain analytics firm, Bubblemaps, the Solana-based (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) tokens were moved from community funds, with no explanation from the project team or Davis, who acknowledged having co-created the MELANIA meme coin. 
A total of 50 million MELANIA tokens were sent to the wallet &#8220;Cq2Tj6&#8221; before being distributed to multiple other addresses. More than $3 million was transferred to centralized exchanges, two new positions worth $6 million each were established, and $500,000 has already been liquidated.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">3/ Instead, 50M MELANIA (~$30M) were moved from the community funds to wallet Cq2Tj6, then split across multiple addresses: • Two new $6M positions were opened • Over $3M was sent to exchanges • $500K has already been sold <a href="https://t.co/8hOwrwhqU7">pic.twitter.com/8hOwrwhqU7</a>
&mdash; Bubblemaps (@bubblemaps) <a href="https://twitter.com/bubblemaps/status/1909305073118871694?ref_src=twsrc%5Etfw">April 7, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The analytics firm also pointed out that this lack of transparency comes on the heels of a $2 million sell-off reported last week, which used the same one-sided liquidity strategy Davis employed during the LIBRA token crash in February. Davis, who has acknowledged launching both MELANIA and LIBRA, has been associated with a recurring pattern of pump-and-dump meme coin schemes.
"No one from the MELANIA team has addressed this. Not the movements. Not the selling," reported Decrypt citing Bubblemaps.
The White House did not immediately respond to <a href="http://pro.benzinga.com">Benzinga&#8217;s</a> request for comment. 
Bubblemaps&nbsp;also stated last month on X that it discovered that Hayden Davis, had been "secretly selling $MELANIA tokens using single-sided liquidity."
SEE ALSO:&nbsp;<a href="https://benzinga.com/trading-ideas/long-ideas/25/04/44697177/marjorie-taylor-greene-buys-the-dip-congresswoman-purchases-shares-of-apple-amazon-nike-" target="_blank" rel="noreferrer noopener">Marjorie Taylor Greene Buys The Dip: Congresswoman Purchases Shares Of Apple, Amazon, Nike And More Following Tariff-Related Sell-Off</a>
Why It Matters:&nbsp;The MELANIA meme coin,&nbsp;linked to U.S. First Lady&nbsp;Melania Trump, has seen a significant decline in value.&nbsp;In March the <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44268979/melania-trumps-official-memecoin-worth-over-13-billion-barely-two-months-ago-is-now-valued-a">coin&#8217;s value had fallen</a> to $367 million from over $13 billion in just two months. The coin&#8217;s continued decline contrasts with the broader meme coin market&#8217;s recovery during that period.
Similarly, the Official Trump (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>) meme coin, associated with President Donald Trump, has also seen a significant drop in value. The coin&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44335357/donald-trumps-official-meme-coin-worth-14-5-billion-on-inauguration-day-is-down-to-2-3-billion">market cap shrank</a> from $14.5 billion to $2.3 billion, reflecting broader challenges for Trump-branded cryptocurrencies amid a volatile meme coin market.
Dominika Stobiecka, co-founder of Toku, a token compliance platform, had earlier told Decrypt that such insider trading in cryptocurrencies is not just unethical, it transforms the market into a &#8220;rigged game&#8221; in which  "retail investors lose confidence, participation drops, and the entire system suffers."
MELANIA is currently trading at $0.5150, down over 90% from its launch-day high. In comparison, TRUMP is priced at $7.65, reflecting more than an 85% drop from its peak, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..&amp;tblci=GiD1tFFNH-r-bulyXzVS-mm-BVNR3nb6Ojb3DSX9l1ZrFSCN1Vcox-6pnqzj16QvMO-ISg" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>
<ul>
<li>READ MORE:&nbsp;<a href="https://benzinga.com/general/social-media/25/04/44705344/ray-dalio-says-dont-make-the-mistake-of-thinking-whats-happening-now-is-due-to-trump-tariffs" target="_blank" rel="noreferrer noopener">Ray Dalio Says Don&#8217;t Make The Mistake Of Thinking What&#8217;s Happening Now Is Due To Trump Tariffs &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$MELANIA

$SOL

$TRUMP

MELANIA Meme Coins Worth $30 Million Quietly Sold — No Word From Project Team: Report

Amplify YieldShares Oil Hedged MLP Income ETF

AMLX

Amylyx Pharmaceuticals Announced That The First Participant Has Been Dosed In LUMINA, Phase 1, Multinational, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Clinical Trial Of AMX0114 In People Living With Amyotrophic Lateral Sclerosis

Agreement includes the use of Tonix's TNX-1500, as part of an immunomodulatory regimen to reduce rejection of Makana's genetically engineered pig organs in xenotransplantation.
 &nbsp;

TNXP

Tonix Pharmaceuticals And Makana Therapeutics Announce Collaboration Combining Tonix's Anti-CD40L Monoclonal Antibody (TNX-1500) With Makana's Genetically Engineered Organs In Preclinical And Clinical Xenotransplantation Studies

Neogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEOG#NASDAQ">NEOG</a>) reported quarterly earnings of $0.10 per share which missed the analyst consensus estimate of $0.11 by 9.09 percent. This is a 16.67 percent decrease over earnings of $0.12 per share from the same period last year. The company reported quarterly sales of $220.98 million which missed the analyst consensus estimate of $224.88 million by 1.74 percent. This is a 3.42 percent decrease over sales of $228.81 million the same period last year.

NEOG

Neogen Q3 2025 Adj EPS $0.10 Misses $0.11 Estimate, Sales $220.98M Miss $224.88M Estimate

B of A Securities analyst Justin Post maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Buy and lowers the price target from $257 to $225.

AMZN

B of A Securities Maintains Buy on Amazon.com, Lowers Price Target to $225

Chardan Capital analyst Geulah Livshits initiates coverage on Palvella Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PVLA#NASDAQ">PVLA</a>) with a Buy rating and announces Price Target of $50.

Initiation

PVLA

Chardan Capital Initiates Coverage On Palvella Therapeutics with Buy Rating, Announces Price Target of $50

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Gladstone Investment Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GAIN#NASDAQ">GAIN</a>)</h3>
<ul>
<li>On March 11, Gladstone Investment announced the sale of its portfolio company Nocturne Luxury Villas, Inc. to an affiliate of Calera Capital. The company's stock fell around 12% over the past five days and has a 52-week low of $11.42.</li>
<li>RSI Value: 26.1</li>
<li>GAIN Price Action: Shares of Gladstone Investment fell 1.1% to close at $11.77 on Tuesday.</li>
<li>Edge Stock Ratings: 47.83 Momentum score. </li>
</ul>
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/quote/GAIN"><img loading="lazy" decoding="async" width="491" height="170" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09034835/image-43.png" alt="" class="wp-image-863185" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09034835/image-43.png 491w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09034835/image-43-300x104.png 300w" sizes="(max-width: 491px) 100vw, 491px" /></a></figure>
<h3 class="wp-block-heading">S&amp;P Global Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>S&amp;P Global will release first quarter 2025 results on Tuesday, April 29. The company's stock fell around 13% over the past five days and <a href="https://www.benzinga.com/quote/SPGI">has a 52-week low</a> of $407.69.</li>
<li>RSI Value: 29</li>
<li>SPGI Price Action: Shares of S&amp;P Global gained 0.7% to close at $441.50 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">SPGI stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="925" height="830" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035004/image-44.png" alt="" class="wp-image-863191" style="width:551px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035004/image-44.png 925w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035004/image-44-300x269.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035004/image-44-768x689.png 768w" sizes="(max-width: 925px) 100vw, 925px" /></a></figure>
<h3 class="wp-block-heading">First Commonwealth Financial Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCF#NYSE">FCF</a>)</h3>
<ul>
<li>On March 18, First Commonwealth Financial received all regulatory approvals required to complete CenterGroup merger. The company's stock fell around 8% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/fcf">low of $12.41.</a></li>
<li>RSI Value: 26.3</li>
<li>FCF Price Action: Shares of First Commonwealth Financial gained 0.6% to close at $14.16 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409">FCF shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0409"><img loading="lazy" decoding="async" width="887" height="832" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035058/image-45.png" alt="" class="wp-image-863198" style="width:496px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035058/image-45.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035058/image-45-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09035058/image-45-768x720.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
Don't miss out on the full BZ Edge Rankings—<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">compare all the key stocks now</a>. 
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Trading Ideas

GAIN

SPGI

Top 3 Financial Stocks That Could Blast Off In April

CarMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) will release its fourth-quarter financial results before the <a href="https://www.benzinga.com/quote/kmx/earnings">opening bell on Thursday, April 10</a>.
Analysts expect the Richmond, Virginia-based company to report quarterly earnings at 66 cents per share, up from 32 cents per share in the year-ago period. CarMax projects quarterly revenue of $5.97 billion, compared to $5.63 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Dec. 19, 2024, CarMax reported better-than-expected third-quarter earnings and sales.
CarMax shares fell 0.6% to close at $73.31 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/KMX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Wedbush analyst Seth Basham reiterated an Outperform rating with a price target of $100 on April 1, 2025. This analyst has an accuracy rate of 66%.</li>
<li>JP Morgan analyst Rajat Gupta maintained an Underweight rating and cut the price target from $72 to $65 on March 27, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Evercore ISI Group analyst Michael Montani maintained an Outperform rating and slashed the price target from $107 to $105 on March 11, 2025. This analyst has an accuracy rate of 60%.</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Hold rating and raised the price target from $72 to $88 on Dec. 20, 2024. This analyst has an accuracy rate of 70%.</li>
<li>RBC Capital analyst Steven Shemesh maintained an Outperform rating and increased the price target from $99 to $103 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
</ul>
Considering buying KMX stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="597" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09031739/image-42-1024x597.png" alt="" class="wp-image-863111" style="width:545px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09031739/image-42-1024x597.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09031739/image-42-300x175.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09031739/image-42-768x448.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/04/09031739/image-42.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44684755/top-3-industrials-stocks-you-may-want-to-dump-this-month">Top 3 Industrials Stocks You May Want To Dump This Month</a> </li>
</ul>
Photo via Shutterstock

CarMax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

HC Wainwright &amp; Co. analyst Amit Dayal maintains Westport Fuel Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WPRT#NASDAQ">WPRT</a>) with a Buy and lowers the price target from $22 to $7.

WPRT

HC Wainwright & Co. Maintains Buy on Westport Fuel Systems, Lowers Price Target to $7

Endeavour Silver Reported First Quarter 2025 Production Of 1,205,793 Silver Ounces (Oz) And 8,338 Gold Oz, For Silver Equivalent Production Of 1.9 Million Oz

TD Securities analyst Andrew Charles maintains Kura Sushi USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) with a Hold and lowers the price target from $72 to $44.

KRUS

TD Securities Maintains Hold on Kura Sushi USA, Lowers Price Target to $44

Seaport Global analyst David Joyce upgrades Sirius XM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIRI#NASDAQ">SIRI</a>) from Neutral to Buy and announces $27 price target.

Upgrades

SIRI

Seaport Global Upgrades Sirius XM Holdings to Buy, Announces $27 Price Target

Given current uncertainty, Delta is not reaffirming full year 2025 financial guidance and will provide an update later in the year as visibility improves.

Delta Air Lines Is Not Restating Its 2025 Outlook Due To Ongoing Uncertainty And Will Provide An Update Later As Visibility Improves

Press Releases

Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

Legal

Contact Levi & Korsinsky by April 7, 2025 Deadline to Join Class Action Against Neumora Therapeutics, Inc.(NMRA)

NMRA Deadline: NMRA Investors with Losses in Excess of $100K Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Lawsuit First Filed by The Firm

NMRA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit

Faruqi & Faruqi Reminds Neumora Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 - NMRA

NMRA Deadline in 1 Day: Kessler Topaz Meltzer & Check, LLP Reminds Neumora Therapeutics, Inc. (NMRA) Investors of Filing Deadline in Class Action Lawsuit

NMRA IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Neumora Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 7 Deadline in Securities Class Action First Filed by the Firm – NMRA

Neumora Therapeutics, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before April 7, 2025 to Discuss Your Rights - NMRA

Penny Stocks

NMRA Investors Have Opportunity to Lead Neumora Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Neumora Therapeutics, Inc. Class Action: Levi & Korsinsky Reminds Neumora Therapeutics, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of April 7, 2025 – NMRA

Comments

Neumora Therapeutics

Noticias

Últimas noticias sobre Neumora Therapeutics (NASDAQ:NMRA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL